NCT00446095 - Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

October 31, 2010

Conditions

Lymphoma

Interventions

DRUG

fostamatinib

200 mg PO BID

Trial Locations (11)

Research Site, New York

Research Site, Rochester

Research Site, Atlanta

Research Site, Cleveland

Research Site, Indianapolis

Research Site, Rochester

Research Site, Chicago

Research Site, Omaha

Research Site, Los Angeles

Research Site, Stanford

Research Site, Boston